Dr. Jonas Welge
- Intellectual Property
- Pharma & Life Sciences
- IT-Law & Data Protection Law
- Commercial Agreements
Jonas Welge is a Senior Associate and part of NEUWERK's IP/IT team and Life Sciences Focus Group.
Jonas advises clients in the field of intellectual property law, technology and data protection law as well as M&A.
He has particular experience in advising companies in the life sciences, biotechnology and pharmaceutical sectors, with a focus on the licensing and commercialization of IP rights as well as commercial contracts.
In addition to his work as an attorney, Jonas teaches classes on antitrust law and civil law at the University of Economics and Management (FOM) in Hamburg.
Before he joined NEUWERK in 2018, Jonas studied law with a focus on Intellectual Property Law at University of Freiburg, Germany, and at University of Grenoble, France.
He later worked at the Institute for Intellectual Property and Commercial Law at the University of Freiburg.
In his doctoral thesis (2017), Jonas focuses on antitrust and patent-law-aspects of so-called "Pay-for-Delay-Agreements" between pharmaceutical companies.
During his legal clerkship at the Higher Regional Court of Hamburg, Jonas worked for the Federal Chancellery’s Foreign Policy and Security Department as well as the Federal Foreign Office at the German Consulate in Atlanta, USA.
Die kartellrechtliche Zulässigkeit von Pay-for-Delay-Vereinbarungen in den USA und der EU
(Beiträge zum Europäischen Wirtschaftsrecht –Duncker & Humblot, Berlin 2017)
Rechtliche Fragen der Kommerzialisierung von KI-Systemen,
Plattform Life Sciences, 2/2021, S. 50
Generics (UK) u. a.: EuGH nimmt Stellung zu Pay-for-Delay-Vereinbarungen
WuW 2020, 120ff.
Der datenschutzrechtliche Kopieanspruch im Arbeitsrecht
NZA 2019, 1110 ff. (together with Willem Schulte)
EuGH, 29.07.2019 - C-40/17: Webseitenbetreiber sind für Social Plugins datenschutzrechtlich (mit-)verantwortlich, NDCompliance 8/2019, 6 (together Börge Seeger and Marten Rauscher)